Study of Maintenance Electroconvulsive Therapy Alongside Clozapine in Treatment-Resistant Schizophrenia Patients Who Respond to Initial ECT
Led by Central Institute of Mental Health, Mannheim · Updated on 2026-02-03
140
Participants Needed
14
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Schizophrenia is a severe mental disorder with significant human and societal costs. Approximately 15-30% of patients do not respond to all known antipsychotic treatments, including clozapine, which is considered the current gold-standard for treatment-resistant cases. This trial aims to evaluate whether adding maintenance electroconvulsive therapy mECT to clozapine treatment improves outcomes for patients who have already responded to an initial course of routine ECT. The goal is to determine if mECT can delay relapse or increase the number of relapse-free patients compared to clozapine treatment alone in clozapine-resistant schizophrenia CRS.
CONDITIONS
Brief Title
Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
Research Team
A
Alexander Sartorius, Prof
C
Christian R Wolf, Prof
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Current diagnosis of schizophrenia according to DSM-5
BPRS total score greater than 45
History of clozapine-resistant schizophrenia or intolerance/contraindications to clozapine
Improvement after an initial course of routine electroconvulsive therapy
You will not qualify if you...
Diagnosis of major neurocognitive disorder (dementia), severe substance-use disorder, affective disorders with psychotic symptoms, or any personality disorder
Inability to read or write German
Pregnancy or breastfeeding
Any general medical condition that contraindicates electroconvulsive therapy
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Acute Electroconvulsive Therapy (ECT) Series
Duration - Up to 9 weeks
Participants receive an acute series of routine ECT treatments while on stable antipsychotic medication to achieve clinical improvement.
Up to 18 ECT treatments with 2-3 sessions per week
Maintenance Treatment
Duration - 28 weeks
Participants who respond to the acute ECT series are randomized to either maintenance ECT plus treatment as usual or treatment as usual alone for ongoing treatment.
Visits as per treatment schedule during 28 weeks
Follow-up
Duration - 12 months
Participants are followed for 12 months after completion of maintenance treatment to monitor relapse and other outcomes.
Visits scheduled during follow-up phase
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Long-Term Safety and Tolerability Study of LB-102 in Adults With Stable Schizophrenia Over 52 Weeks
20-Year Follow-up Study on Early Treatment and Relapse Effects in First Episode Psychosis
Study Comparing Two Formulations of Paliperidone Palmitate Injection 3M in Chinese Adults with Schizophrenia
Randomized, Open-label, Multicenter, Multiple-dose Bioequivalence Study
A Phase 2 Study to Assess Safety and Effectiveness of Different Olanzapine Dosing Schedules in Adults with Schizophrenia
Long-term Study of SEP-363856 Tablets for Adults with Schizophrenia to Evaluate Safety and Tolerability
Open-Label Long-Term Study of ML-007C-MA for Adults with Schizophrenia Evaluating Safety and Effectiveness
Phase 1 Study of LY03020 Oral Tablets to Assess Safety, Tolerability, and Pharmacokinetics in Chinese Adults with Stable Schizophrenia or Healthy Volunteers
Evaluating Deep Transcranial Magnetic Stimulation dTMS for Reducing Antipsychotic-Induced Weight Gain in Schizophrenia Effects of Food Cue-Induced Craving in a Randomized, Crossover, Sham-Controlled Trial
Evaluating Brenipatide with Standard Care Compared to Placebo in Adults with Schizophrenia A Double-Blind, Randomized Phase 2 Study
Evaluating Safety and Early Effects of Oral LTX-001 Compared to Placebo in Adults With Worsening Schizophrenia Symptoms
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Study protocol of a German multi-center, observer-blind, randomized, and actively controlled parallel-group trial comparing maintenance electroconvulsive therapy to treatment as usual for relapse prevention in clozapine resistant schizophrenia.
Anton Deicher, Sebastian Karl, Marie-Luise Otte...